Life Settlements

Permanent life insurance policies — whole life, universal life, and similar products — are designed to be held for the insured’s lifetime. But circumstances change. A policyholder’s children may have grown up and become financially independent, eliminating the original need for insurance. The estate planning rationale behind the policy may no longer apply. The insured’s business interests may have changed. Premiums may have become a strain in retirement. In all of these cases, the policyholder owns a valuable asset they no longer need.

Until the life settlement market matured, the only options for an unwanted permanent policy were to keep paying premiums, surrender the policy to the carrier for a fraction of its economic value, or let it lapse with no return at all. The life settlement market created a third path: a regulated mechanism for transferring the policy to a buyer who is willing to pay materially more than surrender value because, as an institutional investor with a portfolio of similar policies, the buyer can diversify mortality risk and underwrite the economics professionally.

Industry research has consistently shown that policyholders selling into the life settlement market typically receive several times the cash surrender value the carrier would have paid for the same policy. The market exists because both sides are better off — the seller gets liquidity at a fair price; the buyer acquires an asset whose ultimate cash flow is uncorrelated with the rest of their portfolio.

Life settlements are regulated at the state level in the United States. The vast majority of states have enacted life settlement statutes, most of them based on or aligned with the National Association of Insurance Commissioners (NAIC) Life Settlements Model Act or the National Conference of Insurance Legislators (NCOIL) Life Settlements Model Act. The result is a comprehensive consumer-protection and market-integrity framework that governs every step of a life settlement transaction.

Licensing

Life settlement providers (the institutional buyers) and life settlement brokers (the intermediaries that represent policyholders) must be licensed in the states where they operate. Licensing requires demonstrating financial responsibility, undergoing background checks, paying ongoing fees, and submitting to regulatory examinations.

Disclosure and consent

Statutes mandate detailed disclosures to the selling policyholder: the alternatives to a life settlement (including retention, surrender, and accelerated death benefits), the right to rescind the transaction within a defined window after closing, the identity of the buyer, the gross offer, and the fees and commissions paid out of the proceeds. The selling policyholder must provide explicit written consent, typically including authorization for the buyer to receive ongoing medical information about the insured for the purpose of monitoring policy status.

Insurable interest at issuance

Life settlement transactions involve policies that were originally issued with proper insurable interest — that is, policies that the original policyholder had a legitimate reason to take out at the time of issuance. Insurable interest is the foundational principle that distinguishes legitimate life insurance from wagering on lives. The life settlement market relies on policies that were validly originated and have since become unwanted; it is not a market for newly originated policies created speculatively.

Privacy protections

State statutes impose strict privacy obligations on buyers and brokers regarding the insured’s medical and personal information. Buyers receive redacted medical records for underwriting purposes, and the identity of the insured is protected from disclosure to unauthorized parties. Compliance is enforced through state insurance department oversight.

The combined effect of state regulation, model-act standardization, licensing requirements, and disclosure mandates is that life settlements are one of the more thoroughly regulated alternative asset classes available to institutional investors.

Sea Point Capital does not transact directly with policyholders. Policies enter our underwriting pipeline through a network of licensed intermediaries and qualified institutional counterparties. We work through three principal channels — two in the secondary market and one in the tertiary market:

• •
  Life settlement brokers are licensed intermediaries that represent the policyholder in the secondary market. Their fiduciary duty is to the seller — they shop the policy to multiple licensed buyers and recommend the best available offer. Working through brokers ensures that the policyholder receives competitive market pricing.
• •
  Life settlement providers are licensed buyers that source policies in the secondary market, perform diligence, and either hold them on their own balance sheet or place them with other qualified buyers. Providers act as the regulated counterparty for the formal purchase and may serve as the channel through which buyers like Sea Point ultimately acquire policies.
• •
  Tertiary market counterparties are other institutional holders — funds, family offices, and similar qualified holders — that already own life settlement policies and may sell individual policies or portfolios into the tertiary market. Tertiary transactions are institution-to-institution rather than originated from the policyholder. They occur for a range of reasons, including portfolio rebalancing, fund wind-downs, or pricing dislocations that make a sale attractive to the holder. Acquiring policies through the tertiary market allows Sea Point to capitalize on these dislocations and to source seasoned policies whose performance history is already partially developed.

Every transaction involves the same core documentation set: the original policy, current carrier illustrations, complete medical records for the insured, independent life expectancy (LE) reportslife expectancy (LE) reportsA specialist medical underwriting assessment estimating the mortality curve for a specific insured, based on their medical records and actuarial tables. Buyers use LE reports to model the probability distribution of when a policy will mature. from specialist underwriting firms, verification of premium status, and the standardized disclosure and consent forms required by state statute. Sea Point reviews this documentation in full before any bid is submitted.

The economics of a life settlement are conceptually simple. The buyer pays an upfront purchase price for the policy. The buyer then pays the ongoing premiums required to keep the policy in force. When the insured eventually passes away, the buyer collects the full death benefit from the insurance carrier. The return is the difference between the cash received (the death benefit) and the cash paid (the purchase price plus all premiums paid over the holding period), discounted by the time elapsed.

The mathematics that turns this conceptual model into a tradable asset class is the actuarial assessment of life expectancy. Specialist medical underwriting firms review the insured’s medical records and produce a life expectancy (LE) report estimating the mortality curvemortality curveA probability distribution of mortality outcomes for a given individual or population — expressing the likelihood of death at each future point in time based on actuarial data and medical profile. for that individual. The LE is not a prediction of when a specific person will die; it is a probability distribution of mortality outcomes built from large-sample actuarial data adjusted for the insured’s specific medical profile.

Buyers price a policy by combining the LE distribution with the policy’s premium projections, the death benefit, and a required rate of return. The result is a maximum bid: the price at which acquiring the policy delivers the buyer’s target risk-adjusted return given the modeled mortality distribution. If the seller’s asking price is at or below the buyer’s maximum bid, a transaction can occur.

Returns are therefore driven by two independent factors: (1) the accuracy of the mortality modeling and (2) the buyer’s discipline in not overpaying. Both are skills that compound with experience and scale. Sea Point uses AI-enhanced mortality analysis to refine our own view of the mortality distribution, which we compare against the LE reports we receive — the discrepancies are often where mispricings appear and value is created. We describe this approach in more depth on our Strategy page.

The cash flow pattern of a single life settlement is distinctive: a single large outflow at acquisition, a series of small recurring premium outflows for the holding period, and a single large inflow at maturity when the death benefit is paid. From the day a policy is acquired until the day it matures, the holder is in a net cash-outflow position; the return is realized in a single discrete event at maturity.

Aggregated across a diversified portfolio, the pattern smooths out. Premium outflows occur every month across all policies. Maturities occur intermittently across the portfolio according to the combined mortality curves of the underlying lives. The result is a return profile we describe as ‘step-wise’: shallow ongoing drawdowns from premium payments, punctuated by episodic gains as individual policies mature. Larger and more varied portfolios naturally produce smoother aggregate cash flows. But smoothness is a byproduct, not a goal. Sea Point does not seek diversification for its own sake. We are comfortable holding a concentrated portfolio when each acquisition reflects high conviction — and we treat conviction in individual policies as a more important discipline than artificially spreading exposure across many.

Life settlements are long-duration, inherently illiquid assets. The expected duration of an individual policy reflects the insured’s life expectancy — typically several years, sometimes longer. The actual duration is unknown until the policy matures, since mortality outcomes are probabilistic. Portfolio-level duration is the weighted average of the individual policies.

Liquidity arises primarily through the natural lifecycle of the assets. As individual policies mature, the death benefits create periodic cash events that the portfolio holder can either redeploy into new policies or distribute. A portfolio holder is not dependent on selling policies to a third party to generate liquidity — natural maturities provide it through the underlying mortality process.

Secondary and tertiary markets

Beyond the original life settlement transaction (secondary market) — where a policyholder sells a policy for the first time — there are tertiary markets where institutional holders trade policies among themselves. A tertiary market sale involves a fund or other institutional holder selling a policy it previously acquired, typically because the policy no longer fits the portfolio, the holder is rebalancing, or pricing dislocations create an opportunity to crystallize gains earlier than maturity.

An active tertiary market allow portfolio holders to manage their books dynamically rather than holding every policy to maturity. It also provides a market-based check on policy valuations: a policy that can be sold at a premium to its modeled carrying value is by definition mispriced upward in the model, and vice versa. Sea Point monitors these markets continuously and may sell policies opportunistically when tertiary market pricing creates attractive exits relative to the modeled hold-to-maturity return.

Life settlements serve as the capital appreciation engine in a multi-asset insurance-linked portfolio. Their return profile — long-duration, step-wise, mortality-driven, structurally uncorrelated with traditional markets — is exactly the kind of return signature that diversifies a portfolio dominated by equity beta, credit spread risk, or interest rate sensitivity.

Three properties make life settlements particularly valuable as a portfolio component. First, the underlying risk factor — mortality timing — is genuinely unrelated to the economic and financial variables that drive most other asset classes. A recession does not change when an insured will pass away. Second, the asset’s value is ultimately backed by a death benefit contractually guaranteed by a regulated insurance carrier; the principal cash flow is not subject to default risk in the same way a corporate bond is. Third, returns are realized through actual cash distributions over time rather than through marked valuations, which provides a different (and arguably more robust) source of return than mark-to-market alternatives.

In a portfolio that also holds collateralized loans (shorter duration, steadier accretion) and payout annuities (predictable monthly income, opposite mortality exposure), life settlements provide the long-duration capital appreciation that complements the other two assets’ liquidity and stability characteristics. We describe how these three assets work together on our Strategy page.

Investors new to life settlements sometimes ask whether the asset class is ethically defensible. The question is fair, and it deserves a direct answer: life settlements are not only ethically defensible — they create measurable economic and social benefit for the policyholders who participate, and the regulated structure of the market makes the asset class consistent with the kind of stakeholder-aligned investing that ESG frameworks aim to promote.

What life settlements actually do for policyholders

Without a life settlement market, a policyholder who no longer wants or can afford their policy has two options: surrender it back to the insurance carrier for the cash surrender value (often a small fraction of what the policy is economically worth), or let it lapse and receive nothing. Either way, the carrier keeps the difference. The existence of a competitive secondary market transforms this dynamic. The policyholder receives a market-based offer that typically delivers several times the cash surrender value. Industry research has consistently shown that policyholders who sell into the secondary market receive materially more than what carriers would have paid them. That additional value is real money in the hands of people — frequently retirees — at a point in life when liquidity matters.

Aligned, not adversarial, interests

A common but mistaken framing is that life settlement buyers ‘benefit when people die sooner.’ The framing misses two important points. First, the policyholder has already made the decision that the policy is no longer wanted or needed — the buyer’s purchase is what gives the seller liquidity for an unwanted asset, regardless of when the underlying mortality event eventually occurs. Second, the buyer’s role in the transaction is to provide capital and bear risk; the underlying insured’s lifespan is determined by factors entirely outside the buyer’s influence. The buyer-seller relationship is voluntary, fully disclosed, regulated, and economically rational for both parties. It bears no resemblance to a wager.

The ESG case

Life settlements perform well against each pillar of the ESG framework. On the environmental dimension, the asset class has effectively zero direct environmental footprint — there are no operations, no emissions, no resource extraction, no land use. On the social dimension, the asset class delivers material economic benefit to selling policyholders (frequently older Americans on fixed incomes) by giving them access to liquidity at fair-market pricing they could not otherwise obtain. The asset class also helps preserve coverage capacity in the life insurance market by enabling efficient recycling of policies that would otherwise lapse. On the governance dimension, the market is comprehensively regulated, with licensing, disclosure, consent, privacy, and audit requirements imposed at the state level and reinforced by NAIC and NCOIL model statutes. The contractual obligations are clear, the counterparties are licensed, and the documentation requirements are uniform.

Life settlements are a legitimate, regulated, and socially constructive corner of the alternative investment universe. The asset class earned its place in institutional portfolios by aligning the interests of policyholders, buyers, and insurance carriers in a way that benefits each.